3M CoMMM
Price$164.15Intrinsic value$106.6735% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $25.2B+2.5% YoYTTM through 30 Jun 2026
Net Income $3B-28.2% YoYTTM through 30 Jun 2026
Free Cash Flow $4BTTM through 30 Jun 2026

Margins

Current
EBITDA Margin23.9%
Operating Margin18.4%
Net Margin11.9%

Returns

101.5%ROE
8.6%ROA
23.8%ROIC

Balance Sheet Health

Debt / Equity4.26x
Current Ratio1.24x
Net Debt$9.6B
Cash & Equivalents$3B

Quality Metrics

Altman Z-Score4.44
Piotroski F-Score5 / 9
FCF Margin15.8%
Rule of 4016.7
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $24.9B
Diluted EPS$5.63TTM
'19'20'21'22'23'24'25
FY2025: $6.00

Dividend

$1.56Per share, FY20260.92%Yield-20.6%5-yr growth

Capital Allocation

R&D Spend$700M
Capex Intensity3.6%

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.